NPM1 and acute myeloid leukemia: An additional caveat is that mutant NPM1 IHC may rarely detect cytoplasmic NPM1 in AML cases with a negative molecular assay; this may occur if the mutation involving NPM1 is not covered by a “type-specific” RT-PCR assay or occurs in an exon not covered by NGS (36).